|
HSPA1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.191620E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.162220E-01 |
| Normal-vs-Stage2 |
1.044160E-01 |
| Normal-vs-Stage3 |
1.161640E-01 |
| Normal-vs-Stage4 |
1.763960E-01 |
| Stage1-vs-Stage2 |
6.738600E-01 |
| Stage1-vs-Stage3 |
9.735000E-01 |
| Stage1-vs-Stage4 |
2.543600E-01 |
| Stage2-vs-Stage3 |
7.012200E-01 |
| Stage2-vs-Stage4 |
2.032000E-01 |
| Stage3-vs-Stage4 |
2.747400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.155180E-01 |
| Normal-vs-AfricanAmerican |
9.647900E-02 |
| Normal-vs-Asian |
3.772400E-01 |
| Caucasian-vs-AfricanAmerican |
3.661000E-01 |
| Caucasian-vs-Asian |
5.109700E-02 |
| AfricanAmerican-vs-Asian |
3.053500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.694300E-02 |
| Normal-vs-Female |
1.286650E-01 |
| Male-vs-Female |
7.837600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.098760E-01 |
| Normal-vs-Age(41-60Yrs) |
1.390230E-01 |
| Normal-vs-Age(61-80Yrs) |
1.038650E-01 |
| Normal-vs-Age(81-100Yrs) |
1.538400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.702800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.483600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.954400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.594000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.625800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.797800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.454500E-02 |
| Classical-VS-Follicular |
2.58704169198154E-12 |
| Classical-VS-Other |
4.082500E-02 |
| Classical-VS-Normal |
1.547620E-01 |
| Tall-VS-Follicular |
1.495720E-02 |
| Tall-VS-Other |
6.481800E-01 |
| Tall-VS-Normal |
9.664300E-02 |
| Follicular-VS-Other |
1.391000E-01 |
| Follicular-VS-Normal |
5.535600E-02 |
| Other-VS-Normal |
8.088000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.282570E-01 |
| Normal-vs-N1 |
1.184050E-01 |
| N0-vs-N1 |
7.467600E-01 |
|
|
